Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clostridium tetani toxoid antigen |
Is a |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Vaccine product containing Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Vaccine product containing Clostridium tetani and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Vaccine product containing Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Clostridium tetani antigen-containing vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Clostridium tetani and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
Clostridium tetani antigen only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens only paediatric vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Vaccine product containing only Clostridium tetani and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Clostridium tetani and Corynebacterium diphtheriae antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus antigens only pediatric vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
Vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B and inactivated whole Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and inactivated Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae and inactivated whole Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type B and Hepatitis B virus and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
Pediatric vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Vaccine product containing Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Human poliovirus and Measles morbillivirus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Low dose acellular Bordetella pertussis and Clostridium tetani and low dose Corynebacterium diphtheriae antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Hepatitis B virus antigens only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Vaccine product containing only acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Antigen of Clostridium tetani (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |